Home/ Supplements/ Vitamin K/ Vitamin K2 100 mcg

Vitamin K2 100 mcg

product on market Capsule Bronson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 is supported by moderate evidence for promoting calcium deposition in bones and preventing arterial calcification. This ingredient plays a key role in activating proteins that regulate calcium metabolism. The current formulation maintains a high safety profile for general use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K2 100 mcg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
120
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (83% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Microcrystalline Cellulose Magnesium Stearate Silicon Dioxide modified Cellulose capsule
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement for adults, take 1 capsule daily, preferably with a meal or as directed by a healthcare professional.

Warnings & Precautions

Warning: Do not take this product if you are pregnant or nursing. Consult a healthcare professional before taking this product if you have a medical condition or are taking medication, especially anticoagulant drugs.

Do not use if seal under cap is broken or missing.

Keep out of reach of children.

Formulation Notes

Vitamin K2 100 mcg per serving K2 as MK-7

Supports healthy bones and cardiovascular health

Non-GMO Gluten-free Soy-free

Additional Information

Bronson Nutrition since 1960

Store at room temperature.

Lab Tested Made from High Quality Ingredients GMP Good Manufacturing Practice Clinically Researched Ingredients

365 day 100% money back guaranteed Nutrition Questions or Comments? support@bronsonlabs.com Call 1-800-235-3200 Mon. - Fri. 7 AM - 6 PM MST Sat. 8 AM - 4:30 M MST

Metadata

Product Details

UPC / SKUX0026LJAPD
DSLD Entry Date2020-08-23
Product TypeVitamin
FormCapsule
BrandBronson
DSLD ID233285
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.